FrancophonIA/ELRC3.0 huggingface dataset:
English: - oestrogens and progestogens (such as in the contraceptive pill used for birth control), - phenothiazine derivatives (used to treat psychiatric disorders), - somatropin (growth hormone), - sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma), - thyroid hormones (used to treat thyroid gland disorders), - protease inhibitors (used to treat HIV), - atypical antipsychotic medicines (such as olanzapine and clozapine).
Croatian: - estrogene i progestagene (primjerice, u kontracepcijskoj tableti za kontrolu začeća), - derivate fenotiazina (koriste se za liječenje psihijatrijskih poremećaja), - somatropin (hormon rasta), - simpatomimetičke lijekove (poput epinefrina [adrenalina], salbutamola, terbutalina koji se koriste za liječenje astme), - hormone štitnjače (koriste se za liječenje poremećaja štitnjače), - inhibitore proteaze (koriste se za liječenje HIV infekcije), - netipične antipsihotičke lijekove (kao što su klozapin, olanzapin).
English: It must only be used if the solution is clear, colourless, with no solid particles visible.
Croatian: Smije se upotrijebiti samo ako je otopina bistra, bezbojna, bez vidljivih krutih čestica.
English: 8 pens of 3 ml.
Croatian: 8 uložaka od 3 ml.
English: - If your blood sugar is too low (hypoglycaemia), follow the guidance for hypoglycaemia (see box at the end of this leaflet).
Croatian: - ako ste alergični na inzulin glulizin ili bilo koji drugi sastojak ovog lijeka (naveden u dijelu 6) - ako Vam je šećer u krvi prenizak (hipoglikemija), slijedite upute za slučaj hipoglikemije (vidjeti uokvireni tekst na kraju ove Upute o lijeku).
English: 10 secs
Croatian: 10 sek
English: Local hypersensitivity reactions (redness, swelling and itching at the injection site) may occur during treatment with insulin.
Croatian: Tijekom liječenja inzulinom mogu se pojaviti lokalne reakcije preosjetljivosti (crvenilo, oticanje i svrbež na mjestu injiciranja).
English: • Eye reactions
Croatian: Poremećaji oka
English: Shelf life for intravenous use
Croatian: Rok valjanosti za intravensku primjenu
English: Apidra 100 Units/ml solution for injection in a vial Each vial contains 10 ml of solution for injection, equivalent to 1000 Units.
Croatian: Apidra 100 jedinica/ml otopina za injekciju u bočici Jedna bočica sadrži 10 ml otopine za injekciju, što odgovara 1000 jedinica.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Apidra 100 Units/ml solution for injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Apidra 100 jedinica/ml otopina za injekciju inzulin glulizin
English: A 26-week phase III clinical study followed by a 26-week extension safety study was conducted to compare insulin glulisine (0-15 minutes before a meal) with regular human insulin (30-45 minutes before a meal) injected subcutaneously in patients with type 2 diabetes mellitus also using NPH insulin as basal insulin.
Croatian: Kako bi se usporedio inzulin glulizin (primijenjen supkutano 0-15 minuta prije obroka) s običnim ljudskim inzulinom (primijenjenim supkutano 30-45 minuta prije obroka) provedeno je 26-tjedno kliničko ispitivanje faze III te produžetak istoga ispitivanja u trajanju od 26 tjedana u svrhu praćenja sigurnosti u bolesnika sa šećernom bolešću tipa 2 koji su također uzimali NPH inzulin kao bazalni inzulin.
English: Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen 3 ml solution in a cartridge (colourless glass) with a plunger (elastomeric bromobutyl rubber) and a flanged cap (aluminium) with a stopper (elastomeric bromobutyl rubber).
Croatian: Apidra SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici 3 ml otopine u ulošku (bezbojno staklo) s klipom (elastomerna brombutilna guma) i zatvaračem s rubnikom (aluminij) i čepom (elastomerna brombutilna guma).
English: Apidra 100 Units/ml solution for injection in a cartridge 3 ml solution in a cartridge (type I colourless glass) with a plunger (elastomeric bromobutyl rubber) and a flanged cap (aluminium) with a stopper (elastomeric bromobutyl rubber).
Croatian: Apidra 100 jedinica/ml otopina za injekciju u ulošku 3 ml otopine u ulošku (bezbojno staklo tipa I) s klipom (elastomerna brombutilna guma) i zatvaračem s rubnikom (aluminij) i čepom (elastomerna brombutilna guma).
English: Measure your blood sugar level regularly to make sure you get the benefit of the insulin infusion and to make sure that the pump is working properly.
Croatian: Da biste imali koristi od infuzije inzulina i da biste bili sigurni da pumpa ispravno radi, morate redovito mjeriti razinu šećera u krvi.
English: Apidra 100 Units/ml solution for injection in a cartridge Each cartridge contains 3 ml of solution for injection, equivalent to 300 Units.
Croatian: Apidra 100 jedinica/ml otopina za injekciju u ulošku Jedan uložak sadrži 3 ml otopine za injekciju, što odgovara 300 jedinica.
English: Hyperglycaemia
Croatian: HIPERGLIKEMIJA
English: Apidra 100 Units/ml solution for injection in a vial 10 ml solution in a vial (type I colourless glass) with a stopper (flanged aluminium overseal, elastomeric chlorobutyl rubber) and a polypropylene tear-off cap.
Croatian: Apidra 100 jedinica/ml otopina za injekciju u bočici 10 ml otopine u bočici (bezbojno staklo tipa I) s čepom (aluminijski prsten s rubnikom, elastomerna klorbutilna guma) i polipropilenskim zatvaračem koji se otkida.
English: Apidra 100 Units/ml solution for injection in a cartridge is a clear, colourless, aqueous solution with no particles visible.
Croatian: Apidra SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici je bistra, bezbojna, vodena otopina bez vidljivih čestica.
English: Medicines that may cause your blood sugar level to rise (hyperglycaemia) include: - corticosteroids (such as "cortisone" used to treat inflammation), - danazol (medicine acting on ovulation), - diazoxide (used to treat high blood pressure), - diuretics (used to treat high blood pressure or excessive fluid retention), - glucagon (pancreas hormone used to treat severe hypoglycaemia), - isoniazid (used to treat tuberculosis),
Croatian: Lijekovi koji mogu uzrokovati povišenje razine šećera u krvi (hiperglikemiju) obuhvaćaju: - kortikosteroide (poput kortizona, koriste se za liječenje upale), - danazol (lijek koji djeluje na ovulaciju), - diazoksid (koristi se za liječenje visokog krvnog tlaka), - diuretike (koriste se za liječenje visokog krvnog tlaka ili prekomjernog nakupljanja tekućine u tijelu), - glukagon (hormon gušterače, koristi za liječenje teške hipoglikemije), - izoniazid (koristi se za liječenje tuberkuloze),
English: Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen Each pen contains 3 ml of solution for injection, equivalent to 300 Units.
Croatian: Apidra SoloStar 100 jedicica/ml otopina za injekciju u napunjenoj brizgalici Jedna brizgalica sadrži 3 ml otopine za injekciju, što odgovara 300 jedinica.
English: Subcutaneous or intravenous use.
Croatian: Za primjenu pod kožu ili u venu.
English: Keep the cartridge inserted in the pen protected from light.
Croatian: Uložak čuvati umetnut u brizgalicu, zaštićen od svjetlosti.
English: Marketing Authorisation Holder: Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main Germany
Croatian: Sanofi-Aventis Deutschland GmbH 65926 Frankfurt na Majni Njemačka
English: Please check section 6.4 of this SPC for instructions on how to store SoloStar.
Croatian: Za upute o čuvanju brizgalice SoloStar, vidjeti dio 6.4 ovog Sažetka opisa svojstava lijeka.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (cartridge)
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA (uložak)
English: 9 pens of 3 ml.
Croatian: 9 uložaka od 3 ml.
English: Hydrochloric acid, concentrated Sodium hydroxide Water for injections
Croatian: 6.1 Popis pomoćnih tvari metakrezol natrijev klorid trometamol polisorbat 20 kloridna kiselina, koncentrirana natrijev hidroksid voda za injekcije
English: It must only be used if the solution is clear and colourless, not when cloudy or with visible particles.
Croatian: Lijek se smije koristiti samo ako je otopina bistra, bezbojna, a ne ako je zamućena ili sadrži vidljive čestice.
English: The cartridge is sealed in a disposable pre-filled pen.
Croatian: Uložak je ugrađen u napunjenu brizgalicu za jednokratnu uporabu.
English: No increase in the basal insulin dose was needed with insulin glulisine, in contrast to insulin lispro.
Croatian: Za razliku od inzulina lispro, kod primjene inzulina glulizina nije trebalo povećavati dozu bazalnog inzulina.
English: Be familiar with your warning symptoms.
Croatian: Morate poznavati simptome koji Vas upozoravaju na hipoglikemiju.
English: 2 vials of 10ml.
Croatian: 2 bočice od 10 ml
English: Apidra 100 Units/ml solution for injection in a vial Solution for injection in a vial.
Croatian: Apidra 100 jedinica/ml otopina za injekciju u ulošku Otopina za injekciju u ulošku.
English: Each pen contains 3 ml solution, equivalent to 300 Units.
Croatian: Jedna brizgalica sadrži 3 ml otopine (što odgovara 300 jedinica).
English: The glucose-lowering activities of insulin glulisine and regular human insulin are equipotent when administered by intravenous route.
Croatian: Kad se primjenjuju intravenski, inzulin glulizin i obični ljudski inzulin imaju istovjetan učinak na sniženje glukoze.
English: 5 pens of 3 ml.
Croatian: 5 uložaka od 3 ml.
English: Select the dose
Croatian: Pogledajte dio
English: Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen Shelf life after first use of the pen
Croatian: Apidra SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Rok valjanosti nakon prve uporabe brizgalice
English: Apidra 100 Units/ml solution for injection in a vial Shelf life after first use of the vial
Croatian: Apidra 100 jedinica/ml otopina za injekciju u ulošku Rok valjanosti nakon prve uporabe uloška
English: MedDRA
Croatian: Doza
English: Apidra 100 Units/ml solution for injection in a vial Intravenous use
Croatian: Apidra 100 jedinica/ml otopina za injekciju u bočici Intravenska primjena
English: 10 pens of 3 ml.
Croatian: 10 uložaka od 3 ml.
English: Obesity
Croatian: Plodnost
English: GLULISINE - post REGULAR - pre
Croatian: GLULIZIN - poslije OBIČNI - prije
English: 5 vials of 10ml.
Croatian: 5 bočica od 10 ml
English: To prevent any kind of contamination, the use of the pre-filled pen should remain strictly for a single patient use.
Croatian: Da bi se spriječila bilo kakva kontaminacija, brizgalicu za višekratnu uporabu smije koristiti samo jedan bolesnik.
English: 8 cartridges of 3ml.
Croatian: 8 brizgalica od 3 ml.
English: 1 pen of 3 ml.
Croatian: 1 uložak od 3 ml.
English: Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen Insulin glulisine
Croatian: Apidra SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici inzulin glulizin
English: NAME OF THE MEDICINAL PRODUCT Apidra 100 Units/ml solution for injection in a vial Apidra 100 Units/ml solution for injection in a cartridge Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen
Croatian: Apidra 100 jedinica/ml otopina za injekciju u bočici Apidra 100 jedinica/ml otopina za injekciju u ulošku Apidra SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici
English: Apidra 100 Units/ml solution for injection in a vial
Croatian: Apidra 100 jedinica/ml otopina za injekciju u bočici
English: 6 pens of 3 ml.
Croatian: 6 uložaka od 3 ml.
English: Hyperglycaemia (potentially leading to Diabetic ketoacidosis(1))
Croatian: Poremećaji metabolizma i prehrane hipoglikemija hiperglikemija (može dovesti do dijabetičke ketoacidoze
English: 4 vials of 10ml.
Croatian: 4 bočice od 10 ml
English: Apidra 100 Units/ml solution for injection in a cartridge Pens to be used with Apidra 100 units/ml solution for injection in a cartridge Apidra 100 units/ml in cartridges is only suitable for subcutaneous injections from a reusable pen.
Croatian: Apidra 100 jedinica/ml otopina za injekciju u ulošku Brizgalice koje se koriste s lijekom Apidra 100 jedinica/ml otopina za injekciju u ulošku Apidra 100 jedinica/ml u ulošcima prikladna je isključivo za supkutano injiciranje s brizgalicom za višekratnu primjenuu ulošcima je prikladnaan samo za potkožne injekcije iz brizgalice za višekratnu uporabu.
English: Pen body
Croatian: Tijelo brizgalice
English: EU/1/04/285/005 1 cartridge of 3ml EU/1/04/285/006 3 cartridges of 3ml.
Croatian: EU/1/04/285/029 1 brizgalica od 3 ml EU/1/04/285/030 3 brizgalice od 3 ml EU/1/04/285/031 4 brizgalice od 3 ml EU/1/04/285/032 5 brizgalica od 3 ml EU/1/04/285/033 6 brizgalica od 3 ml EU/1/04/285/034 8 brizgalica od 3 ml EU/1/04/285/035 9 brizgalica od 3 ml EU/1/04/285/036 10 brizgalica od 3 ml
English: 1 vial of 10ml.
Croatian: 1 bočica od 10 ml
English: 4 pens of 3 ml.
Croatian: 4 uloška od 3 ml.
English: Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen Handling of the SoloStar pre-filled pen
Croatian: Apidra SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Rukovanje SoloStar napunjenom brizgalicom
English: In a 26-week phase III clinical study comparing insulin glulisine with insulin lispro both injected subcutaneously shortly (0-15 minutes) before a meal in patients with type 1 diabetes mellitus using insulin glargine as basal insulin, insulin glulisine was comparable to insulin lispro for glycaemic control as reflected by changes in glycated haemoglobin (expressed as HbA1c equivalent) from baseline to endpoint.
Croatian: U kliničkom ispitivanju faze III koje je trajalo 26 tjedana uspoređivani su inzulin glulizin i inzulin lispro, oba primijenjena supkutano neposredno prije obroka (0-15 minuta) u bolesnika koji boluju od šećerne bolesti tipa 1 i uzimaju inzulin glargin kao bazalni inzulin.
English: Unopened cartridges:
Croatian: Neotvoreni ulošci:
English: 3 pens of 3 ml.
Croatian: 3 uloška od 3 ml.
English: Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen Solution for injection in a pre-filled pen.
Croatian: Apidra SoloStar 100 jedicica/ml otopina za injekciju u napunjenoj brizgalici Otopina za injekciju u napunjenoj brizgalici.
English: Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen Apidra SoloStar 100 units/ml in a pre-filled pen is only suitable for subcutaneous injections.
Croatian: Apidra SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Apidra 100 jedinica/ml u napunjenoj brizgalici prikladna je isključivo za supkutano injiciranjeu napunjenoj brizgalici je prikladnaan samo za potkožne injekcije.
English: Apidra 100 Units/ml solution for injection in a vial Unopened vials
Croatian: Apidra 100 jedinica/ml otopina za injekciju u ulošku Neotvoreni ulošci
English: Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen Not in-use pens
Croatian: Apidra SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Neupotrijebljene brizgalice
English: Apidra 100 Units/ml solution for injection in a cartridge Solution for injection in a cartridge.
Croatian: Apidra 100 jedinica/ml otopina za injekciju u bočici Otopina za injekciju u bočici.
English: Apidra 100 Units/ml solution for injection in a vial Insulin glulisine
Croatian: Apidra 100 jedinica/ml otopina za injekciju u ulošku inzulin glulizin
English: Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen Apidra SoloStar 100 Units/ml in pre-filled pen is only suitable for subcutaneous injections.
Croatian: Apidra SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Apidra Solostar 100 jedinica/ml u napunjenoj štrcaljki prikladna je isključivo za supkutano injiciranjeu napunjenoj brizgalici je prikladnaan samo za potkožne injekcije.
English: The pharmacokinetic properties of insulin glulisine are generally maintained in patients with renal impairment.
Croatian: Farmakokinetička svojstva inzulina glulizina u načelu ostaju nepromijenjena u bolesnika s oštećenom bubrežnom funkcijom.
English: Apidra 100 Units/ml solution for injection in a cartridge Unopened cartridges
Croatian: Apidra 100 jedinica/ml otopina za injekciju u bočici Neotvorene bočice
English: Look at the vial before you use it. Only use it if the solution is clear, colourless and has no visible particles in it.
Croatian: Smijete je upotrijebiti samo ako je otopina bistra, bezbojna i u njoj nema vidljivih čestica.
English: 9 cartridges of 3ml.
Croatian: 9 brizgalica od 3 ml.
English: 5 cartridges of 3ml.
Croatian: 5 brizgalica od 3 ml.
English: Apidra 100 Units/ml solution for injection in a vial Subcutaneous use
Croatian: Apidra 100 jedinica/ml otopina za injekciju u bočici Supkutana primjena
English: 10 cartridges of 3ml.
Croatian: 10 brizgalica od 3 ml.
English: 1 cartridge of 3ml.
Croatian: 1 brizgalica od 3 ml.
English: 4 cartridges of 3ml.
Croatian: 4 brizgalice od 3 ml.
English: Apidra SoloStar 100 units/ml in pre-filled pen is only suitable for subcutaneous injections.
Croatian: Apidra 100 jedinica/ml u napunjenoj brizgalici prikladna je isključivo za supkutano injiciranjeu napunjenoj brizgalici je prikladnaan samo za potkožne injekcije.
English: Immediate Packaging
Croatian: Put primjene Unutarnje pakiranje Veličina pakovanja
English: Route of Administration
Croatian: Broj (EU) odobrenja
English: It is taken once a day with food.
Croatian: Uzima se jedanput dnevno uz hranu.
English: The full EPAR for Tenofovir disoproxil Zentiva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Tenofovir disoproxil Zentiva nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This means that Tenofovir disoproxil Zentiva is similar to a ‘reference medicine' already authorised in the European Union (EU) called Viread.
Croatian: To znači da je lijek Tenofovir disoproxil Zentiva sličan „referentnom lijeku” koji je već odobren u Europskoj uniji (EU) pod nazivom Viread.
English: In adolescents (from 12 to 18 years of age) its use is only for those who cannot be treated with other first-line nucleotide reverse transcriptase inhibitors (NRTI).
Croatian: U adolescenata (od 12 do 18 godina), primjenjuje se samo u onih bolesnika koje se ne može liječiti drugim nukleotidnim inhibitorima reverzne transkriptaze (NRTI) prve linije liječenja.
English: The company that markets Tenofovir disoproxil Zentiva will ensure that all doctors who are expected to prescribe or use the medicine are provided with educational materials containing important safety information, particularly on the risks and precautions relating to kidney function and the bones.
Croatian: Tvrtka koja stavlja na tržište lijek Tenofovir disoproxil Zentiva osigurat će da svi liječnici od kojih se očekuje da će propisivati ili primjenjivati lijek prime edukativne materijale s važnim informacijama o sigurnosti, osobito o rizicima i mjerama opreza u pogledu funkcije rada bubrega i kostiju.
English: Tenofovir also interferes with the action of an enzyme produced by the hepatitis B virus called ‘DNA polymerase', which is involved in the formation of viral DNA.
Croatian: Tenofovir također ometa djelovanje enzima koji stvara virus hepatitisa B, koji se naziva „DNK polimeraza”, koji sudjeluje u stvaranju virusnog DNK-a.
English: Tenofovir disoproxil Zentiva is available as tablets (245 mg) to be taken by mouth.
Croatian: Lijek Tenofovir disoproxil Zentiva dostupan je u obliku tableta (od 245 mg) koje se uzimaju kroz usta.
English: The Committee recommended that Tenofovir disoproxil Zentiva be approved for use in the EU.
Croatian: Odbor je preporučio odobrenje lijeka Tenofovir disoproxil Zentiva za korištenje u EU-u.
English: This is a summary of the European public assessment report (EPAR) for Tenofovir disoproxil Zentiva.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Tenofovir disoproxil Zentiva.
English: Tenofovir disoproxil Zentiva, taken in combination with other antiviral medicines, reduces the amount of HIV in the blood and keeps it at a low level.
Croatian: Lijek Tenofovir disoproxil Zentiva, kada se uzima u kombinaciji s drugim antivirusnim lijekovima, smanjuje količinu HIV-a u krvi i održava je na niskoj razini.
English: Tenofovir disoproxil Zentiva does not cure HIV infection or AIDS, but it can hold off damage to the immune system and avoid the development of infections and diseases associated with AIDS.
Croatian: Lijekom Tenofovir disoproxil Zentiva ne liječi se infekcija HIV-om ni AIDS, ali njegovom se primjenom može odgoditi narušavanje imunosnog sustava i izbjeći razvoj infekcija i bolesti povezanih s AIDS-om.
English: For patients who have taken medicines to treat HIV infection before, doctors should only prescribe Tenofovir disoproxil Zentiva once they have looked at the antiviral medicines the patient has taken before or the likelihood of the virus's response to antiviral medicines.
Croatian: Bolesnicima koji su prethodno uzimali lijekove za liječenje HIV-a liječnici smiju propisivati lijek Tenofovir disoproxil Zentiva tek nakon što provjere koje je antivirusne lijekove bolesnik prethodno uzimao ili vjerojatnost odgovora virusa na antivirusne lijekove.
English: In adults, it can also be used for those patients with liver damage whose liver does not work properly (decompensated liver disease) and those patients who do not respond to treatment with lamivudine (another medicine for hepatitis B).
Croatian: U odraslih se može upotrebljavati i u bolesnika s oštećenjem jetre čija jetra ne funkcionira normalno (dekompenzirana bolest jetre) te u bolesnika koji ne odgovaraju na liječenje lamivudinom (drugim lijekom za liječenje hepatitisa B).
English: In HIV infection, it blocks the activity of reverse transcriptase, an enzyme produced by HIV that allows it to infect cells and make more viruses.
Croatian: U slučaju infekcije HIV-om on onemogućuje djelovanje reverzne transkriptaze, enzima koji stvara HIV te virusu omogućuje da zarazi stanice i stvori veći broj virusa.
English: Tenofovir disoproxil Zentiva can only be obtained with a prescription and treatment should be started by a doctor who has experience in the treatment of HIV infection or chronic hepatitis B.
Croatian: Lijek Tenofovir disoproxil Zentiva izdaje se samo na liječnički recept, a liječenje mora započeti liječnik s iskustvom u liječenju infekcija HIV-om ili kroničnog hepatitisa B.
English: Tenofovir disoproxil Zentiva stops the virus making DNA and prevents it from multiplying and spreading.
Croatian: Lijek Tenofovir disoproxil Zentiva onemogućuje da virus stvara DNK i tako sprečava njegovo umnožavanje i širenje.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Tenofovir disoproxil Zentiva have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Tenofovir disoproxil Zentiva nalaze se također u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Tenofovir disoproxil Zentiva has been shown to have comparable quality and to be bioequivalent to Viread.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji zaključio je kako je u skladu sa zahtjevima EU-a potvrđeno da Tenofovir disoproxil Zentiva posjeduje usporedivu kakvoću te je bioekvivalentan s lijekom Viread.
English: Tenofovir disoproxil Zentiva is an antiviral medicine used to treat patients aged 12 years and above infected with human immunodeficiency virus type 1 (HIV 1), a virus that causes acquired immune deficiency syndrome (AIDS).
Croatian: Tenofovir disoproxil Zentiva antivirusni je lijek koji se upotrebljava za liječenje bolesnika u dobi od 12 godina i više zaraženih virusom humane imunodeficijencije tipa 1 (HIV1), virusom koji uzrokuje sindrom stečene imunodeficijencije (AIDS).